Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp. (MERINO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02176122
Recruitment Status : Terminated (Secondary to third interim analysis by the study DSMB.)
First Posted : June 26, 2014
Last Update Posted : November 27, 2017
Sponsor:
Collaborators:
International Society of Chemotherapy
Australian Society for Antimicrobials
Queensland Clinical Trials & Biostatistics Centre
Australasian Society for Infectious Diseases
Information provided by (Responsible Party):
Professor David L. Paterson, The University of Queensland

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 7, 2017
Actual Study Completion Date : August 7, 2017